Top Markets
#1 OSK OSK +15.48%
#2 Ardor Ardor +7.80%
#3 MarsCoin MarsCoin +7.36%
#4 Tornado Cash Tornado Cash +6.57%
#5 HOME HOME +5.86%
#6 UnifAI Network UnifAI Network +4.33%
#7 AI XOVIA AI XOVIA +4.25%
#8 Story Story +4.12%
#9 Cash Cat Cash Cat +3.55%
#10 Anvil Anvil +2.93%
Coin of the day
OSK OSK
Settings
Language
ENGLISH
Currency
USD
Theme
Sionna Therapeutics, Inc. Sionna Therapeutics, Inc.

Sionna Therapeutics, Inc.

SION
Rank in Stocks #16567
Operating as a biopharmaceutical company, Sionna Therapeutics, Inc. is... Operating as a biopharmaceutical company, Sionna Therapeutics, Inc. is dedicated to transforming the treatment landscape for individuals with cystic fibrosis. This is achieved by developing innovative medicines designed to restore the normal function of the cystic fibrosis transmembrane conductance regulator.
Share Price
$6.36
Last synced: 2026-09-01
Market Cap
$287.06M
Change (1 day)
5.44%
Change (1 year)
-74.96%
Country
US
Trade Sionna Therapeutics, Inc. (SION)

Category

Healthcare
Revenue for Sionna Therapeutics, Inc. (SION)
Revenue in Sep 2026 TTM: 0
According to Sionna Therapeutics, Inc. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Sionna Therapeutics, Inc. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH